Whitehawk Therapeutics (WHWK) Receivables - Net (2016 - 2024)
Whitehawk Therapeutics (WHWK) posted quarterly Receivables - Net of $5.9 million for Q4 2024, up 7.56% year-over-year from $5.5 million in Q1 2024, and down 9.74% quarter-over-quarter from $6.5 million in Q3 2024.
Whitehawk Therapeutics (WHWK) Receivables - Net (2016 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Receivables - Net for 6 consecutive years, with $5.9 million the latest figure, recorded in Q4 2024.
- In Q4 2024, Receivables - Net rose 7.56% year-over-year to $5.9 million; the TTM figure through Dec 2024 stood at $5.9 million (up 7.56% YoY), while the FY2024 annual figure was $5.9 million, up 7.56% from the prior year.
- Receivables - Net fell to $5.9 million in Q4 2024 per WHWK's latest filing, from $6.5 million in the prior quarter.
- Across five years, Receivables - Net topped out at $14.1 million in Q4 2020 and bottomed at $1.9 million in Q4 2022.
- Historically, Receivables - Net has averaged $5.1 million across 4 years, with a median of $5.5 million in 2023.
- Annual changes were most pronounced in 2023 — Receivables - Net soared 194.74% — and 2024, when it fell 11.36%.
- Whitehawk Therapeutics' Receivables - Net stood at $14.1 million in 2020, then sank by 86.84% to $1.9 million in 2022, then jumped by 194.74% to $5.5 million in 2023, then advanced by 7.56% to $5.9 million in 2024.
- Business Quant data shows WHWK's Receivables - Net at $5.9 million in Q4 2024, $6.5 million in Q3 2024, and $5.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.90 Mn |
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Sep 30, 2024 | 6.54 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Mar 31, 2024 | 4.93 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Dec 31, 2023 | 5.49 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Sep 30, 2023 | 5.72 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 5.57 Mn |
| Mar 31, 2023 | 5.57 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 2.26 Mn |
| Sep 30, 2022 | 2.26 Mn |